184 related articles for article (PubMed ID: 36119078)
1. Serum soluble Fas ligand is a severity and mortality prognostic marker for COVID-19 patients.
Saleki K; Shirzad M; Javanian M; Mohammadkhani S; Alijani MH; Miri N; Oladnabi M; Azadmehr A
Front Immunol; 2022; 13():947401. PubMed ID: 36119078
[TBL] [Abstract][Full Text] [Related]
2. Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus.
Vincent FB; Kandane-Rathnayake R; Koelmeyer R; Harris J; Hoi AY; Mackay F; Morand EF
Lupus Sci Med; 2020 Jun; 7(1):. PubMed ID: 32546562
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significances of serum soluble fas and soluble fas ligand in chronic hepatitis B].
Jun EJ; Han JY; Sun HS
Korean J Hepatol; 2006 Dec; 12(4):507-14. PubMed ID: 17237628
[TBL] [Abstract][Full Text] [Related]
4. [Change in serum levels of soluble Fas and soluble FasL in patients with multiple organ dysfunction syndrome].
Fu Y; Xiao QM; Wang T; Chen XH; Ai YH
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Nov; 18(11):691-4. PubMed ID: 17092425
[TBL] [Abstract][Full Text] [Related]
5. Soluble form of fas and fas ligand in BAL fluid from patients with pulmonary fibrosis and bronchiolitis obliterans organizing pneumonia.
Kuwano K; Kawasaki M; Maeyama T; Hagimoto N; Nakamura N; Shirakawa K; Hara N
Chest; 2000 Aug; 118(2):451-8. PubMed ID: 10936140
[TBL] [Abstract][Full Text] [Related]
6. The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage fluid in lung cancer patients.
Erdoğan B; Uzaslan E; Budak F; Karadağ M; Ediger D; Oral B; Göral G; Ege E; Gözü O
Tuberk Toraks; 2005; 53(2):127-31. PubMed ID: 16100648
[TBL] [Abstract][Full Text] [Related]
7. Expression of soluble Fas and soluble FasL in human nucleus pulposus cells.
Sun Z; Wan ZY; Liu ZH; Guo YS; Yin JB; Duan CG; Gao Y; Li T; Wang HQ; Luo ZJ
Int J Clin Exp Pathol; 2013; 6(8):1567-73. PubMed ID: 23923075
[TBL] [Abstract][Full Text] [Related]
8. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
Perianayagam MC; Murray SL; Balakrishnan VS; Guo D; King AJ; Pereira BJ; Jaber BL
J Lab Clin Med; 2000 Oct; 136(4):320-7. PubMed ID: 11039853
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha and Fas/Fas ligand signaling pathways in chronic spontaneous urticaria.
Grzanka R; Damasiewicz-Bodzek A; Kasperska-Zajac A
Allergy Asthma Clin Immunol; 2019; 15():15. PubMed ID: 30911316
[TBL] [Abstract][Full Text] [Related]
10. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in advanced melanoma.
Mouawad R; Khayat D; Soubrane C
Melanoma Res; 2000 Oct; 10(5):461-7. PubMed ID: 11095407
[TBL] [Abstract][Full Text] [Related]
11. Soluble Fas ligand blocks destructive corneal inflammation in mouse models of corneal epithelial debridement and LPS induced keratitis.
Gregory-Ksander M; Perez VL; Marshak-Rothstein A; Ksander BR
Exp Eye Res; 2019 Feb; 179():47-54. PubMed ID: 30365944
[TBL] [Abstract][Full Text] [Related]
12. Elevated Soluble Fas and FasL in Cerebrospinal Fluid and Serum of Patients With Anti-N-methyl-D-aspartate Receptor Encephalitis.
Ding YW; Pan SY; Xie W; Shen HY; Wang HH
Front Neurol; 2018; 9():904. PubMed ID: 30410466
[No Abstract] [Full Text] [Related]
13. Triangle of cytokine storm, central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1.
Saleki K; Banazadeh M; Miri NS; Azadmehr A
Rev Neurosci; 2022 Feb; 33(2):147-160. PubMed ID: 34225390
[TBL] [Abstract][Full Text] [Related]
14. Soluble Fas/FasL ratio as a marker of vasculopathy in children and adolescents with sickle cell disease.
Adly AA; Ismail EA; Andrawes NG; Mahmoud MM; Eladawy R
Cytokine; 2016 Mar; 79():52-8. PubMed ID: 26765484
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of the Fas/FasL system in mononuclear cells recovered from peritoneal fluid of women with endometriosis.
Sturlese E; Salmeri FM; Retto G; Pizzo A; De Dominici R; Ardita FV; Borrielli I; Licata N; Laganà AS; Sofo V
J Reprod Immunol; 2011 Dec; 92(1-2):74-81. PubMed ID: 21978769
[TBL] [Abstract][Full Text] [Related]
16. [Detection of FasL mRNA, sFasL and their regulatory effect on T lymphocyte subsets in patients with severe acute pancreatitis].
Qin Y; Liao P; He S; Yin Y; Song S; Hu J; Zheng P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Nov; 29(11):1189-92. PubMed ID: 24200068
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases and soluble Fas/FasL system as novel regulators of apoptosis in children and young adults on chronic dialysis.
Musiał K; Zwolińska D
Apoptosis; 2011 Jul; 16(7):653-9. PubMed ID: 21516345
[TBL] [Abstract][Full Text] [Related]
18. Fas ligand exerts its pro-inflammatory effects via neutrophil recruitment but not activation.
Dupont PJ; Warrens AN
Immunology; 2007 Jan; 120(1):133-9. PubMed ID: 17233740
[TBL] [Abstract][Full Text] [Related]
19. Distinct effects of soluble and membrane-bound fas ligand on fibroblast-like synoviocytes from rheumatoid arthritis patients.
Audo R; Calmon-Hamaty F; Papon L; Combe B; Morel J; Hahne M
Arthritis Rheumatol; 2014 Dec; 66(12):3289-99. PubMed ID: 25078097
[TBL] [Abstract][Full Text] [Related]
20. Circulating soluble Fas ligand correlates with disease activity in Graves' hyperthyroidism.
Wang CY; Zhong WB; Chang TC; Tsai YF
Metabolism; 2002 Jun; 51(6):769-73. PubMed ID: 12037733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
